Document Detail

Varied distributions of late gadolinium enhancement found among patients meeting cardiovascular magnetic resonance criteria for isolated left ventricular non-compaction.
Jump to Full Text
MedLine Citation:
PMID:  23421977     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
ABSTRACT: BACKGROUND: Late gadolinium enhancement (LGE) is identified frequently in LVNC. However, the features of this findings are limited. The purpose of the present study was to describe the frequency and distribution of LGE in patients meeting criteria for left ventricular non-compaction (LVNC), as assessed by cardiovascular magnetic resonance (CMR). METHODS: Forty-seven patients (37 males and 10 females; mean age, 39 +/- 18 years) considered to meet standard CMR criteria for LVNC were studied. The LGE images were obtained 15 +/- 5 min after the injection of 0.2 mmol/kg of gadolinium-DTPA using an inversion-recovery sequence, and analyzed using a 17-segment model. RESULTS: Mean number of non-compacted segments per patient was 7.4 +/- 2.5 and the NC:C was 3.2 +/- 0.7. Non-compaction was most commonly noted in the apical segments in all patients. LGE was present in 19 of the 47 patients (40%), and most often located in the ventricular septum. The distribution of LGE was subendocardial (n = 5; 6%), mid-myocardial (n = 61; 68%), subepicardial (n = 10; 11%), and transmural (n = 14; 15%) in total of 90 LGE (+) segments. CONCLUSIONS: In patients considered to meet criteria for LVNC, LGE distributions visible were strikingly heterogeneous with appearances potentially attributable to three or more distinct cardiomyopathic processes. This may be in keeping with previous suggestions that the criteria may be of low specificity. Further work is needed to determine whether conditions such as dilated cardiomyopathy, previous myocardidtis or ischaemic heart disease increase the apparent depth of non-compact relative to compact myocardium.
Authors:
Junyi Wan; Shihua Zhao; Huaibing Cheng; Minjie Lu; Shiliang Jiang; Gang Yin; Xiaojin Gao; Yuejin Yang
Related Documents :
23435837 - A high meld score, combined with the presence of hepatitis c, is associated with a poor...
23282287 - Renal replacement therapy with net fluid removal lowers intra-abdominal pressure and vo...
23217287 - Eus finding of geographic hyperechoic area is an early predictor for severe acute pancr...
22950037 - Clinical features of allergic bronchopulmonary aspergillosis in korea.
10435357 - Patients' attitude toward consultations by a physician without a white coat in japan.
9143567 - Surgical treatment for splenic hydatidosis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-20
Journal Detail:
Title:  Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance     Volume:  15     ISSN:  1532-429X     ISO Abbreviation:  J Cardiovasc Magn Reson     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815616     Medline TA:  J Cardiovasc Magn Reson     Country:  -    
Other Details:
Languages:  ENG     Pagination:  20     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): J Cardiovasc Magn Reson
Journal ID (iso-abbrev): J Cardiovasc Magn Reson
ISSN: 1097-6647
ISSN: 1532-429X
Publisher: BioMed Central
Article Information
Download PDF
Copyright ©2013 Wan et al; licensee BioMed Central Ltd.
open-access:
Received Day: 10 Month: 3 Year: 2012
Accepted Day: 18 Month: 1 Year: 2013
collection publication date: Year: 2013
Electronic publication date: Day: 20 Month: 2 Year: 2013
Volume: 15 Issue: 1
First Page: 20 Last Page: 20
PubMed Id: 23421977
ID: 3610171
Publisher Id: 1532-429X-15-20
DOI: 10.1186/1532-429X-15-20

Varied distributions of late gadolinium enhancement found among patients meeting cardiovascular magnetic resonance criteria for isolated left ventricular non-compaction
Junyi Wan1 Email: wanjunyi911@yahoo.com.cn
Shihua Zhao1 Email: cjrzhaoshihua2009@163.com
Huaibing Cheng1 Email: worldwidely@tom.com
Minjie Lu1 Email: luminjie@163.com
Shiliang Jiang1 Email: jiangsl_2008@163.com
Gang Yin1 Email: cardiacbmeyg@163.com
Xiaojin Gao2 Email: gaoxiaojin@yahoo.com.cn
Yuejin Yang2 Email: cjryangjuejin@163.com
1Department of Radiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, People’s Republic of China
2Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, People’s Republic of China

Background

Left ventricular non-compaction (LVNC) is a disorder characterized by numerous prominent ventricular trabeculations and deep intratrabecular recesses [1], high mortality and morbidity rates from heart failure, systemic thromboemboli, and malignant ventricular arrhythmias [2-6]. It can occur in isolation or in association with congenital cardiac malformations, genetic syndromes, or neuromuscular disorder. Echocardiography is usually the initial cardiac imaging modality used to characterize myocardial pathologies [7-9]. Recently, cardiovascular magnetic resonance (CMR) has been increasingly used to describe the morphological appearance of the ventricular non-compaction [10-13]. In addition, late gadolinium-enhanced CMR has been found to be useful for detecting myocardial fibrosis. However, the descriptions of late gadolinium enhancement (LGE) features are limited in these reports.

The purpose of this retrospective study is to describe the frequency and distribution of LGE in patients considered to meet CMR cine imaging criteria for LVNC.


Methods
Study patients

The study was conducted between April 2006 and January 2011 in our hospital. We enrolled 47 consecutive LVNC patients with first a diagnosis of LVNC. The diagnosis of LVNC was based on the presence of the following CMR and clinical criteria [14]: (a) appearance of 2 distinct myocardial layers; (b) prominent myocardial trabeculations and deep intertrabecular recesses communicating with the left ventricular cavity; (c) end-diastolic ratio of non-compacted-to-compacted(NC:C) myocardium >2.3:1, and (d) absence of other known co-existing cardiac abnormalities. Coronary artery disease (>50% diameter luminal stenosis in any of the major coronary arteries or the major coronary artery branches) was excluded by invasive coronary angiography in some but not all patients, according to the clinical judgment at the time of diagnosis by the clinical physician in this study. All patients gave informed consent, and the study was approved by the institutional ethics committee.

CMR protocol

All CMR exams were performed using a 1.5-T unit (Avanto; Siemens Healthcare, Erlangen, Germany) with a high-performance gradient system (maximum gradient amplitude, 45 mT/m; maximum slew rate, 200 mT/m/ms). Twelve-element matrix coils (6 anterior and 6 posterior) equipped with the scanner and wireless vector electrocardiograph gating triggering were activated for data acquisition. All imaging acquisitions were captured under breath control. Scout transversal and sagittal images were acquired followed by a half-Fourier acquisition single shot turbo spin echo sequence (HASTE: repetition time/echo time [TR/TE] = 700/42 ms; voxel size = 2.5 × 1.5 × 6.0 mm; flip angle = 160°) for the exact determination of the long-axis, 4-chamber, and short-axis plane position. Retrospective electrocardiographic gating cine images were acquired in three long-axis views (LV two-chamber and four-chamber long-axis, and LV outflow tract) and a contiguous set of short-axis sections encompassing the entire LV using true fast imaging with steady-state free precession (TrueFISP: TR/TE = 40.0/1.1 ms; voxel size = 2.0 × 2.0 × 6.0 mm; flip angle = 62°). Fifteen ± 5 min after the injection of 0.2 mmol/kg of gadolinium-DTPA (Magnevist; Schering, Berlin, Germany) with an inversion-recovery sequence, the LGE images were obtained in a standard short axis view covering the entire ventricle, and in long axis views (horizontal and vertical long-axis and LV outflow tract).

CMR analysis

All CMR data were transferred to a workstation (Siemens Medical Systems) for analysis. The LV end-diastolic diameter, LV end-diastolic volume, LV end-systolic volume, and LV ejection fraction were calculated from the short axis cine images. The NC:C myocardium in diastole was calculated for each of the three long-axis views, and only the maximal ratio was used for analysis.

The presence or absence of LGE was qualitatively determined for each LV myocardial segment using the 17 segments model, according to the American Heart Association recommendation [15] by reviewing all short and long axis contrast-enhanced images. Patterns of LGE were defined as subendocardial, subepicardial, mid-myocardial, or transmural (≥75% of any segmental wall thickness) on visual analysis by a consensus of 2 independent observers.

Statistical analysis

All values are expressed as the mean ± SD or counts (percentage). Clinical and CMR characteristics were compared using a Student’s t-test for continuous variables and a chi-square test or Fisher exact test for non-continuous variables in two groups. A two-tailed P-value <0.05 was considered statistically significant. Statistical analysis was performed using the SPSS software package (SPSS 16.0; SPSS, Inc., Chicago, IL, USA).


Results
Patient characteristics

The clinical characteristics of the entire group are summarized in Table 1. Forty-seven patients were considered to fulfil the imaging criteria of LVNC; the mean age was 39 ± 18 years (range, 13–78 years) and 37 (79%) were male. Of the 47 patients, 42 (89%) were severely symptomatic (New York Heart Association [NYHA] functional classes III and IV). All (n = 19; 100%) LGE (+) patients were in NYHA functional class III/IV. Comparing to LGE (-) patients, a non-significant trend towards an increasing percentage (n = 23; 82%) was observed (P = 0.07). In addition, LGE (+) patients had non-significantly lower LVEF, when compared with LGE (-) patients (23 ± 8 vs. 29 ± 15%; P = 0.06). Over 24-h ambulatory Holter ECG, premature ventricular contractions (PVCs) and non-sustained ventricular tachycardia (NSVT) were significantly more common in LGE (+) patients (PVCs: 79% vs. 29%; p = 0.001; and NSVT: 47% vs.7%; p = 0.003). The mean values of LV end-diastolic diameter, LV volumes, mass, number of non-compacted segments, and non-compacted/compacted ratio between the two groups was not statistically significant.

CMR findings

Three hundred fifty (44%) LV segments were considered to fulfil the definition of non-compaction; the mean number of LV non-compacted segments per patient was 7.4 ± 2.5 and the NC:C was 3.2 ± 0.7. Non-compaction was most commonly noted in the apical segments in all patients. Basal-septal segment involvement was not noted in any patient (Figure 1).

LGE was evident in 19 (40%) of the 47 patients. LGE was present in all 17 segments, not only involved non-compacted segments but also normal segments of the heart. Totally, 90(28%) LV segments showed LGE. Seventy-two (80%) LGE (+) LV segments were located in compacted segments, most commonly in the ventricular septum (n = 40; 44%), while only 18 (20%) LGE (+) LV segments were in non-compacted segments (Figure 2). The mean number of LGE (+) segments per patient was 5.1 ± 3.6. The distribution of LGE was subendocardial (n = 5; 6%), mid-myocardial (n = 61; 68%), subepicardial (n = 10; 11%), and transmural (n = 14; 15%) in total of 90 LGE (+) segments (Figure 3).


Discussion

LVNC has a wide spectrum of clinical and pathophysiological findings [16]. Clinical manifestations range from asymptomatic status to heart failure, arrhythmias, and systemic thromboemboli [17,18]. Echocardiographic criteria [1,7] for this disease based on the findings of a two-layered myocardium, with evidence of deep intertrabecular recesses filled with blood from the left ventricular cavity, along with a ratio of NC:C > 2.0:1.

CMR is becoming increasingly widely used in assessment of suspected LVNC. Petersen et al. [11] found that a ratio of NC:C >2.3 in diastole distinguished pathological non-compaction with values for sensitivity and specificity, and positive and negative predictions of 86, 99, 75, and 99%, respectively. Jacquier et al. [19] found that a trabeculated left ventricular mass above 20% of the global LV mass is highly sensitive and specific for the diagnosis of LVNC. However, Kawel et al. [20] reported that a NC:C > 2.3 could be found in 6% of a large cohort of subjects without clinically recognized cardiovascular pathology. Their data showed that the proposed criteria are unlikely to have adequate specificity.

In agreement with previous studies, we observed LGE in approximately 40% patients considered to meet criteria for LVNC. The possibly pathophysiological mechanisms leading to LGE in LVNC have not been determined. Jenni et al. [21] described the coronary microcirculatory dysfunction may possibly account for ischemia and fibrosis in non-compacted and compacted myocardial segments in LVNC. Coronary artery embolism may be considered to account for subendocardial or transmural LGE in young adults (such as cases 2, 6 and 15). Furthermore, most of the remaining LGE (-) studies would, in themselves, pass for those resulting from dilated cardiomyopathy and/or previous myocarditis.

Nucifora et al. [22] found the presence and extent of LGE were independently related to LVEF. In this present study, we compare the LGE (+) and LGE (-) patients, and find that LGE (+) group have lower LVEF, the p value of LVEF is close to significance (P = 0.06). The presence of LGE is associated with ventricular arrhythmias on ambulatory Holter ECG in patients meeting criteria for LVNC. The results need to be confirmed by further studies with a larger sample size.

Limitations

Our study has a number of limitations. It was conducted at a single center with a relatively small sample size, and the diagnosis was based on CMR cine appearances in relation to clinical findings. However, not all patients had coronary artery disease ruled out by invasive coronary angiography. More thorough documentation of all previous investigations and findings would have been desirable. Clinical follow-up data were not available so the relationship between LGE and prognosis in LVNC patients remains unknown.


Conclusions

In patients considered to meet criteria for LVNC, LGE distributions visible were strikingly heterogeneous with appearances potentially attributable to three or more distinct cardiomyopathic processes. This is in keeping with previous suggestions that the criteria may be of low specificity. Further work is needed to determine whether conditions such as dilated cardiomyopathy, previous myocardidtis or ischaemic heart disease increase the apparent depth of non-compact relative to compact myocardium.


Competing interests

The authors declare that they have no competing interests.


Authors’ contributions

JYW, SHZ and BCH conceived and designed the study. JYW drafted the manuscript. SHZ reviewed and edited the manuscript. MJL, GY and SLJ carried out images analyses. XJG and YJY were responsible for cases selected and analysis. All authors read and approved the final manuscript.


Authors’ information

The study was supported by grant No. 81130029 from the key projects of National Natural Science Foundation of China and by grant No. 2009–1004 from Research Foundation of Capital Medical Development.


References
Chin TK,Perloff JK,Williams RG,Jue K,Mohrmann R,Isolated noncompaction of left ventricular myocardium. A study of eight casesCirculationYear: 1990825071310.1161/01.CIR.82.2.5072372897
Ichida F,Hamamichi Y,Miyawaki T,Ono Y,Kamiya T,Akagi T,Hamada H,Hirose O,Isobe T,Yamada K,Kurotobi S,Mito H,Miyake T,Murakami Y,Nishi T,Shinohara M,Seguchi M,Tashiro S,Tomimatsu H,Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic backgroundJYear: 1999342334010.1016/S0735-1097(99)00170-9
Pignatelli RH,McMahon CJ,Dreyer WJ,Denfield SW,Price J,Belmont JW,Craigen WJ,Wu J,El Said H,Bezold LI,Clunie S,Fernbach S,Bowles NE,Towbin JA,Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathyCirculationYear: 20031082672810.1161/01.CIR.0000100664.10777.B814623814
Murphy RT,Thaman R,Blanes JG,Ward D,Sevdalis E,Papra E,Kiotsekoglou A,Tome MT,Pellerin D,McKenna WJ,Elliott PM,Natural history and familial characteristics of isolated left ventricular non-compactionEurYear: 20052618792
Lilje C,Razek V,Joyce JJ,Rau T,Finckh BF,Weiss F,Habermann CR,Rice JC,Weil J,Complications of noncompaction of the left ventricular myocardium in a paediatric population: a prospective studyEurYear: 20062718556010.1093/eurheartj/ehl112
Oechslin EN,Attenhofer Jost CH,Rojas JR,Kaufmann PA,Jenni R,Long-term follow-up of 34 adults with isolated left ventricular non-compaction: a distinct cardiomyopathy with poor prognosisJYear: 20003649350010.1016/S0735-1097(00)00755-5
Jenni R,Oechslin E,Schneider J,Attenhofer Jost C,Kaufmann PA,Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathyHeartYear: 2001866667110.1136/heart.86.6.66611711464
Stollberger C,Finsterer J,Blazek G,Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disordersAmYear: 20029089990210.1016/S0002-9149(02)02723-6
Stollberger C,Finsterer J,Left ventricular hypertrabeculation/noncompactionJYear: 2004179110010.1016/S0894-7317(03)00514-5
Jassal DS,Nomura CH,Neilan TG,Holmvang G,Fatima U,Januzzi J,Brady TJ,Cury RC,Delayed enhancement cardiac MR imaging in noncompaction of left ventricularmyocardiumJYear: 200684899110.1080/10976640600599502
Pujadas S,Bordes R,Bayes-Genis A,Ventricular non-compaction cardiomyopathy: MRI and pathology findingsHeartYear: 20059158210.1136/hrt.2004.04132715831637
Eitel I,Fuernau G,Walther C,Razek V,Kivelitz D,Schuler G,Thiele H,Delayed enhancement magnetic resonance imaging in isolated non-compaction of ventricular myocardiumClinYear: 200897277910.1007/s00392-007-0630-9
Dursun M,Agayev A,Nisli K,Ertugrul T,Onur I,Oflaz H,Yekeler E,MR imaging features of ventricular non-compaction: emphasis on distribution and pattern of fibrosisEurYear: 2010741475110.1016/j.ejrad.2009.01.015
Petersen SE,Selvanayagam JB,Wiesmann F,Robson MD,Francis JM,Anderson RH,Watkins H,Neubauer S,Left ventricular non-compaction: insights from cardiovascular magnetic resonance imagingJYear: 200546101510.1016/j.jacc.2005.03.045
Cerqueira MD,Weissman NJ,Dilsizian V,Jacobs AK,Kaul S,Laskey WK,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart AssociationCirculationYear: 20021055394210.1161/hc0402.10297511815441
Lofiego C,Biagini E,Pasquale F,Ferlito M,Rocchi G,Perugini E,Bacchi-Reggiani L,Boriani G,Leone O,Caliskan K,ten Cate FJ,Picchio FM,Branzi A,Rapezzi C,Wide spectrum of presentation and variable outcomes of isolated left ventricular noncompactionHeartYear: 200793657110.1136/hrt.2006.08822916644854
Aras D,Tufekcioglu O,Ergun K,Ozeke O,Yildiz A,Topaloglu S,Deveci B,Sahin O,Kisacik HL,Korkmaz S,Clinical features of isolated ventricular noncompaction in adults longterm clinical course, echocardiographic properties, and predictors of left ventricular failureJYear: 2006127263310.1016/j.cardfail.2006.08.002
Stanton C,Bruce C,Connolly H,Brady P,Syed I,Hodge D,Asirvatham S,Friedman P,Isolated left ventricular noncompaction syndromeAmYear: 20091041135810.1016/j.amjcard.2009.05.062
Jacquier A,Thuny F,Jop B,Giorgi R,Cohen F,Gaubert JY,Vidal V,Bartoli JM,Habib G,Moulin G,Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular noncompactionEurYear: 201031109810410.1093/eurheartj/ehp595
Kawel N,Nacif M,Arai AE,Gomes AS,Hundley WG,Johnson WC,Prince MR,Stacey RB,Lima JA,Bluemke DA,Trabeculated (noncompacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosisCircYear: 2012533576610.1161/CIRCIMAGING.111.971713
Jenni R,Wyss CA,Oechslin EN,Kaufmann PA,Isolated ventricular non-compaction is associated with coronary microcirculatory dysfunctionJYear: 2002394504
Nucifora G,Aquaro GD,Pingitore A,Masci PG,Lombardi M,Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severityEurYear: 2011132170610.1093/eurjhf/hfq222

Figures

[Figure ID: F1]
Figure 1 

Distribution of non-compaction. The bars represent the percentage of segments with non-compaction in given segments.



[Figure ID: F2]
Figure 2 

Distribution of LGE. The bars represent the percentage of segments with LGE in given segments. LGE=late gadolinium enhancement.



[Figure ID: F3]
Figure 3 

CMR appearances of all 47 patients considered to meet criteria for LVNC. For each patient, two SSFP images are shown and, on the right, one late gadolinium enhancement image, with a black and white frame if it is considered to show fibrosis. m = male or f = female, age given in years, LVEF = left ventricular ejection fraction. LVEDI = left ventricular end-diastolic volume index in ml/m2. NSVT + = non-sustained ventricular tachycardia documented.



Tables
[TableWrap ID: T1] Table 1 

Clinical and cardiac magnetic resonance imaging characteristics of 47 patients with isolated ventricular non-compaction


 
Total patients (n =47)
LGE status
 
    LGE(+) (n =19) LGE(-) (n =28) P-value
Age (yrs)
39 ± 18
43 ± 14
36 ± 20
0.16
Gender male, n (%)
37 (79%)
13 (68%)
24 (86%)
0.16
Weight (kg)
67 ± 16
68 ± 16
66 ± 15
0.65
NYHA functional class III/IV
42 (89%)
19 (100%)
23 (82%)
0.07
Symptoms
 
 
 
 
Chest pain, n (%)
5 (11%)
2 (11%)
3 (11%)
0.98
Syncope, n (%)
4 (9%)
2 (11%)
2 (7%)
0.68
Systemic thrombo-embolism
3(6%)
1 (5%)
2 (7%)
0.80
Electrocardiogram
 
 
 
 
Left bundle branch block
7 (15%)
3 (16%)
4 (14%)
0.89
Right bundle branch block
5 (11%)
2 (11%)
3 (11%)
0.98
Atrial fibrillation
10 (21%)
4 (21%)
6 (21%)
0.98
24 h ambulatory Holter ECG
 
 
 
 
PVCs
49%
79%
29%
0.001
NSVT
23%
47%
7%
0.003
Non-compacted segments per patient
7.4 ± 2.5
6.9 ± 1.9
7.8 ± 2.7
0.26
Non-compacted/compacted ratio
3.2 ± 0.7
3.0 ± 0.6
3.4 ± 0.7
0.09
CMR Parameters
 
 
 
 
LV end-diastolic diameter (mm)
69 ± 10
69 ± 9
69 ± 11
0.92
LV end-diastolic volume (ml)
243 ± 97
250 ± 90
239 ± 103
0.67
LV end-systolic volume (ml)
189 ± 94
198 ± 88
179 ± 99
0.50
LV ejection fraction (%)
27 ± 13
23 ± 8
29 ± 15
0.06
LV mass (g) 124 ± 44 135 ± 50 117 ± 38 0.17

Data are expressed as mean ± SD. or as number of patients (percentage). NYHAn New York Heart Association. PVCs premature ventricular contractions. NSVT non-sustained ventricular tachycardia. LV left ventricular.



Article Categories:
  • Research

Keywords: Cardiomyopathy, Cardiac magnetic resonance, Late gadolinium enhancement.

Previous Document:  Sex differences in lipid peroxidation and fatty acid levels in recent onset schizophrenia.
Next Document:  Palladium Catalyzed Decarboxylative Rearrangement of N-Alloc Indoles.